Skip to content

Good mental health associated with excellent adherence among people taking ART for prevention

Canada: PrEP use now could save considerable sums in the future

Cabotegravir and rilpivirine effective for HIV maintenance therapy at 96 weeks

FRAX fracture prediction tool underestimates fracture risk in people with HIV

Sustained virological response represents a long-term cure for people with hepatitis C treated with sofosbuvir

Inflammation and gut leakage remains elevated in people with HIV despite early antiretroviral treatment

Screening may miss pre-cancerous anal lesions in women with HIV

Re-infection due to ongoing risk probably the cause of HCV recurrence after SVR

Sofosbuvir/ledipasvir raises some antiretroviral levels in HIV/HCV coinfected people